Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy

Title
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Authors
Keywords
HIF-1, Inhibitors, Nanoplatforms, Drug delivery systems, Combination therapy
Journal
CANCER LETTERS
Volume 530, Issue -, Pages 110-127
Publisher
Elsevier BV
Online
2022-01-16
DOI
10.1016/j.canlet.2022.01.012

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now